Browsing Tag
SABCS
1 post
Lilly’s Phase 3 EMBER-3 trial results set to shake up breast cancer treatment landscape
Eli Lilly and Company (NYSE: LLY) announced it will present data from its Phase 3 EMBER-3 trial for…
Business news, market intelligence, and global industry analysis.